Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
WallStPal · PDF guide
EWTX Insider Trading: Insider Buys and Sells · https://wallstpal.com/stock/ewtx/insider-trading/ · saved 2026-10-28

About this page

Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.

How to read it

Form 4
The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
Buy (P) and Sell (S)
Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
Value
Shares times price, as reported on the filing.
10b5-1
A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
Late filing
A Form 4 filed more than two business days after the trade.
Vs. S&P 500
How the stock did after the trade minus how the overall market did in the same weeks.

A real example

In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.

Explain it like I'm 13

If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.

Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.

Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
Insider tradingForm 4

Edgewise Therapeutics, Inc. (EWTX) Insider Trading

7 open-market trades reported since Jul 2, 2026: 0 purchases worth $0 and 7 sales worth $9.78M.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Kevin KochCEO0$01$785KAug 14, 2026
Joanne M. DonovanCMO0$02$413KAug 14, 2026
Alan J. RussellChief Scientific Officer0$02$8.14MAug 14, 2026
Behrad DerakhshanChief Business Officer0$01$223KAug 14, 2026
John R. MooreGeneral Counsel0$01$220KAug 14, 2026

All trades

EWTX insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Aug 14Aug 12Kevin KochCEOCEO▼ SELL17,97143.68$785K−26%Form 4 ↗
Aug 14Aug 12Joanne M. DonovanCMOCMO▼ SELL6,52243.85$286K−36%Form 4 ↗
Aug 14Aug 12Alan J. RussellChief Scientific OfficerChief Scientific Officer▼ SELL5,90143.73$258K−16%Form 4 ↗
Aug 14Aug 12Behrad DerakhshanChief Business OfficerChief Business Officer▼ SELL5,10043.81$223K−14%Form 4 ↗
Aug 14Aug 12John R. MooreGeneral CounselGeneral Counsel▼ SELL5,01643.82$220K−22%Form 4 ↗
Aug 14Aug 13Joanne M. DonovanCMOCMO▼ SELL2,91943.41$127K−25%Form 4 ↗
Jul 2Jul 1Alan J. RussellChief Scientific OfficerChief Scientific Officer▼ SELL10b5-1200,00039.41$7.88M−89%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings